TY - JOUR
T1 - Infantile fibrosarcoma with an EGFR kinase domain duplication
T2 - Underlining a close relationship with congenital mesoblastic nephroma and highlighting a similar morphological spectrum
AU - van Spronsen, R.
AU - Kester, L. A.
AU - Knops, R. R.G.
AU - van de Sande, M. A.J.
AU - van Leenders, G. J.L.H.
AU - de Laat, P. C.J.
AU - Stortelder, E.
AU - Korpershoek, E.
AU - van Noesel, M. M.
AU - Meister, M. T.
AU - Koerkamp, M. J.A.Groot
AU - de Graaf, N.
AU - Giovannoni, I.
AU - Tops, B. B.J.
AU - de Krijger, R. R.
AU - ter Horst, S. A.J.
AU - Flucke, U.
AU - Alaggio, R.
AU - Hiemcke-Jiwa, L. S.
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2022/4
Y1 - 2022/4
N2 - Infantile fibrosarcoma (IFS) and congenital mesoblastic nephroma (CMN) are locally aggressive tumors primarily occurring in infants. Both IFS and the cellular subtype of CMN show overlapping morphological features and an ETV6-NTRK3 fusion, suggesting a close relationship. An activating alteration of EGFR, based on an EGFR kinase domain duplication (KDD), occurs in a subset of CMNs lacking an NTRK3 rearrangement, especially in the classic and mixed type. So far no EGFR-KDDs have been detected in IFS. We describe four pediatric tumors at the extremities (leg, n = 2; foot and arm n = 1) with histological features of IFS/CMN. Two cases showed classic IFS morphology while two were similar to classic/mixed type CMN. In all cases, an EGFR-KDD was identified without detection of a fusion gene. There were no abnormalities of the kidneys in any of the patients. This is the first description of IFS with an EGFR-KDD as driver mutation, supporting that IFS and CMN are similar lesions with the same morphological and genetic spectrum. Pathologists should be aware of the more fibrous variant of IFS, similar to classic/mixed type CMN. Molecular analyses are crucial to treat these lesions adequately, especially with regard to the administration of tyrosine kinase inhibitors.
AB - Infantile fibrosarcoma (IFS) and congenital mesoblastic nephroma (CMN) are locally aggressive tumors primarily occurring in infants. Both IFS and the cellular subtype of CMN show overlapping morphological features and an ETV6-NTRK3 fusion, suggesting a close relationship. An activating alteration of EGFR, based on an EGFR kinase domain duplication (KDD), occurs in a subset of CMNs lacking an NTRK3 rearrangement, especially in the classic and mixed type. So far no EGFR-KDDs have been detected in IFS. We describe four pediatric tumors at the extremities (leg, n = 2; foot and arm n = 1) with histological features of IFS/CMN. Two cases showed classic IFS morphology while two were similar to classic/mixed type CMN. In all cases, an EGFR-KDD was identified without detection of a fusion gene. There were no abnormalities of the kidneys in any of the patients. This is the first description of IFS with an EGFR-KDD as driver mutation, supporting that IFS and CMN are similar lesions with the same morphological and genetic spectrum. Pathologists should be aware of the more fibrous variant of IFS, similar to classic/mixed type CMN. Molecular analyses are crucial to treat these lesions adequately, especially with regard to the administration of tyrosine kinase inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=85122620743&partnerID=8YFLogxK
U2 - 10.1016/j.anndiagpath.2021.151885
DO - 10.1016/j.anndiagpath.2021.151885
M3 - Article
C2 - 35032896
AN - SCOPUS:85122620743
SN - 1092-9134
VL - 57
JO - Annals of Diagnostic Pathology
JF - Annals of Diagnostic Pathology
M1 - 151885
ER -